Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
about
Hay fever in adolescents and adults.Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials.The effect of improving primary care depression management on employee absenteeism and productivity. A randomized trial.Treatment of allergic rhinitis is associated with improved attention performance in children: the Allergic Rhinitis Cohort Study for Kids (ARCO-Kids).Next generation antihistamines: therapeutic rationale, accomplishments and advances.Optimal duration of allergic rhinitis clinical trials.Keys to successful management of patients with allergic rhinitis: focus on patient confidence, compliance, and satisfaction.Emedastine difumarate: a review of its potential ameliorating effect for tissue remodeling in allergic diseases.Allergic rhinitis: indicators of quality of life.A national audit of pollen immunotherapy for children in the United Kingdom: patient selection and programme safety.Patient perceptions of allergic rhinitis and quality of life: findings from a survey conducted in europe and the United StatesEconomic Evaluation of Quality-of-Life Improvement with Second-Generation Antihistamines and Montelukast in Patients with Allergic Rhinitis.A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis.Effects of fexofenadine and desloratadine on subjective and objective measures of nasal congestion in seasonal allergic rhinitis.Comparison of the efficacy, safety and quality of life provided by fexofenadine hydrochloride 120 mg, loratadine 10 mg and placebo administered once daily for the treatment of seasonal allergic rhinitis.Impact of obesity on work productivity and role disability in individuals with and at risk for diabetes mellitus.Method for a homogeneous distribution of pollens in an environmental exposure chamber.
P2860
Q33949990-08E8297E-DDB1-46B3-BA4B-BEBF461956E3Q34221237-34995C09-A147-4ED3-842B-CFD7B20778A8Q34312681-50F7F54A-BF2A-43B9-9DD4-75F5B01F9FEEQ34361692-17F1EFBA-A30A-49A8-A1BF-25D801DDF634Q34660867-6881E200-3242-4F6E-86B1-86CA27D9C3E6Q36281063-B8753A4B-11B2-41FA-BD6B-4B140C8A9D5EQ36826600-5D1D1388-B5AD-4906-B661-595E812FFE37Q37532584-460E5318-E921-4402-872D-1A6C06431CBCQ37704240-BF97102D-1807-4575-88D6-1C82ECCC368EQ37901535-BEC91CD1-D275-4EDC-BD14-DCAB908ED30BQ40617626-7EB8A3ED-31B9-44ED-8353-2488231F66DDQ42026758-69855BAD-15DE-47B9-BDDC-9099C18E09BEQ43987754-E0DD2119-4EDC-4E20-AC3E-B8624BC943F9Q44173557-B1E221AB-CF88-4C4E-B29F-BA22926AB9DEQ49075893-BFD0F10A-48CF-42A5-9F34-0E305B27A070Q50593987-DADBDC56-CC64-4997-B825-858FDA0149ACQ51528156-B537A445-C27B-41FD-8437-39E558324AE2
P2860
Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Once-daily fexofenadine HCl im ...... th seasonal allergic rhinitis.
@en
type
label
Once-daily fexofenadine HCl im ...... th seasonal allergic rhinitis.
@en
prefLabel
Once-daily fexofenadine HCl im ...... th seasonal allergic rhinitis.
@en
P2093
P1476
Once-daily fexofenadine HCl im ...... th seasonal allergic rhinitis.
@en
P2093
Meltzer EO
Thompson AK
P304
P356
10.1016/S1081-1206(10)62671-3
P577
1999-10-01T00:00:00Z